G
Georg Ertl
Researcher at Catholic University of Korea
Publications - 4
Citations - 1710
Georg Ertl is an academic researcher from Catholic University of Korea. The author has contributed to research in topics: Quality of life & Fabry disease. The author has an hindex of 2, co-authored 4 publications receiving 1285 citations. Previous affiliations of Georg Ertl include Pompeu Fabra University.
Papers
More filters
Journal ArticleDOI
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
John W. Eikelboom,Stuart J. Connolly,Jackie Bosch,Gilles R. Dagenais,Robert G. Hart,Olga Shestakovska,Rafael Diaz,Marco Alings,Eva Lonn,Sonia S. Anand,Petr Widimsky,Masatsugu Hori,Alvaro Avezum,Leopoldo S. Piegas,Kelley R. Branch,Jeffrey L. Probstfield,Deepak L. Bhatt,Jun Zhu,Yan Liang,Aldo P. Maggioni,Patricio Lopez-Jaramillo,Martin O'Donnell,Ajay K. Kakkar,Keith A.A. Fox,Alexander Parkhomenko,Georg Ertl,Stefan Störk,Matyas Keltai,Lars Rydén,Nana Pogosova,Antonio L. Dans,Fernando Lanas,Patrick J. Commerford,Christian Torp-Pedersen,Tomek J. Guzik,Peter Verhamme,Dragos Vinereanu,Jae-Hyung Kim,Andrew Tonkin,Basil S. Lewis,Camilo Felix,Khalid Yusoff,P. Gabriel Steg,Kaj Metsärinne,Nancy Cook Bruns,Frank Misselwitz,Edmond Chen,Darryl P. Leong,Salim Yusuf +48 more
TL;DR: Among patients with stable atherosclerotic vascular disease, those assigned to rivaroxaban (2.5 mg twice daily) plus aspirin had better cardiovascular outcomes and more major bleeding events than those assign to aspirin alone.
Journal ArticleDOI
Gene Mutations Versus Clinically Relevant Phenotypes: Lyso-Gb3 Defines Fabry Disease
Markus Niemann,Arndt Rolfs,Stefan Störk,Bart Bijnens,Frank Breunig,Meinrad Beer,Georg Ertl,Christoph Wanner,Frank Weidemann +8 more
TL;DR: The data show that the biomarker lyso-Gb3 may identify the clinically relevant agalA mutations leading to Fabry disease.
Journal ArticleDOI
Book Review Difficult Cardiology III Edited by Graham Jackson. 419 pp., illustrated. London, Martin Dunitz, 1997. (Distributed by Mosby, St. Louis.) $99.50. 1-85317-406-8
Short communication Is health-related quality of life an independent predictor of survival in patients with chronic heart failure? ☆
Hermann Faller,Stefan Störk,Marion Schowalter,Thomas Steinbüchel,Verena Wollner,Georg Ertl,Christiane E. Angermann +6 more
TL;DR: The data suggest that the prognostic value of patients' HRQoL reflects confounding with the severity of disease and comorbid depression, and only the mental health component of SF-36 and the disease-specific HRZoL remained significant.